Novaliq

Developer of reformulation of drug for ocular therapeutics

placeHeidelberg, Baden-wurttemberg, Germany calendar_todayFounded 2007 groups30 employees language novaliq.com

Registered entities

Investor mix

3 investors on record; lead investors include Dievini.

Investor typeCountShare
Venture capital133%
Other / undisclosed267%
Coming soon